MRCM
HALO icon

M&R Capital Management’s Halozyme HALO Stock Holding History

M&R Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32
Closed -$1.18K – 586
2023
Q4 		$1.18K Hold
32
– – ﹤0.01% 598
2023
Q3 		$1.22K Hold
32
– – ﹤0.01% 577
2023
Q2 		$1.15K Hold
32
– – ﹤0.01% 586
2023
Q1 		$1.22K Buy
+32
New +$1.5K ﹤0.01% 574

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

M&R Capital Management's HALO Position: Q1 2024 in Review

M&R Capital Management sold out of Halozyme (HALO) in Q1 2024, closing a stake of 32 shares — an estimated $1.18K sold.

M&R Capital Management first reported a position in HALO in Q1 2023 and held it in 4 quarters. The position peaked at $1.22K in Q3 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • M&R Capital Management reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • M&R Capital Management sold 32 Halozyme shares in Q1 2024, an estimated $1.18K.
  • M&R Capital Management first reported a position in Halozyme in Q1 2023 and held it in 4 quarters.
  • M&R Capital Management's Halozyme position peaked at $1.22K in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on M&R Capital Management's 13F filing for Q1 2024, filed 2 Apr 2024.